Hannover Medical School
Brief description and aims of work
Hannover Medical School (Medizinische Hochschule Hannover, MHH), founded in 1965, is one of the world's leading university medical centres. With its interdisciplinary research, MHH has strong collaborative links with many academic and industrial research organisations worldwide.
MHH focuses its research activities on unravelling basic mechanisms for translation into clinical research in close collaboration with clinical facilities. Building on broad expertise in medicine and life sciences, with particular knowhow in our three main research areas (immunology and infectious diseases; transplantation and regeneration; biomedical technology and implants), MHH scientists study human diseases and develop innovative strategies for diagnosis, prevention and therapy. Our research foci reflect our major clinical strengths. MHH's clinical excellence is world-class, especially in cochlear implants, lung transplantation and novel treatment regimens for viral hepatitis. For many other conditions, we also produce numerous innovations in the search for novel treatment options based on small compounds, biomaterials, cell and gene therapy, and tissue engineering. Our clinical research arena includes a state-of-the-art trial centre dedicated to phase I/II (including first-in-man) studies. Our basic research infrastructure is equally well-equipped, with several core units that ensure top performance in methodologies such as omics platforms and deep sequencing, electron and fluorescence microscopy, cell sorting and manipulation, cellular reprogramming, and structural analysis.
The Department of Pediatric Hematology and Oncology of Hannover Medical School is one of the largest German specialist childhood and adolescent cancer centers and offers phase I-III clinical trials. It also hosts the ALL-BFM Study Group’s biostatistical office and the working group office of GPOH (Society for Pediatric Oncology and Hematology) for implementation and validation of data bases for clinical trials. The Department has an official pediatric clinical trial office and functions as an ITCC center. Clinical, translational and basic research groups within the Department are dedicated mostly to leukemia research and investigations on pediatric tumor predisposition.